I am a
Home I AM A Search Login

Papers of the Week


2022


Prz Gastroenterol


17


1

The effectiveness of microencapsulated sodium butyrate at reducing symptoms in patients with irritable bowel syndrome.

Authors

Lewandowski K, Kaniewska M, Karłowicz K, Rosołowski M, Rydzewska G
Prz Gastroenterol. 2022; 17(1):28-34.
PMID: 35371361.

Abstract

The aim of the study was to assess the effectiveness of a patented preparation of sodium butyrate in the triglyceride matrix at reducing clinical symptoms and improving quality of life in patients with irritable bowel syndrome (IBS).